Harel Insurance Investments & Financial Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Sell
4,490
-380
-8% -$44.5K ﹤0.01% 237
2026
Q1
$586K Sell
4,870
-1,680
-26% -$194K ﹤0.01% 198
2025
Q4
$689K Buy
6,550
+4,020
+159% +$377K 0.01% 187
2025
Q3
$212K Buy
2,530
+1,800
+247% +$148K ﹤0.01% 283
2025
Q2
$58K Hold
730
﹤0.01% 347
2025
Q1
$66K Sell
730
-430
-37% -$40.1K ﹤0.01% 347
2024
Q4
$115K Sell
1,160
-18,302
-94% -$1.89M ﹤0.01% 245
2024
Q3
$2.22M Sell
19,462
-3,097
-14% -$368K 0.04% 122
2024
Q2
$2.83M Buy
22,559
+884
+4% +$114K 0.05% 108
2024
Q1
$2.87M Sell
21,675
-140
-0.6% -$17.3K 0.06% 106
2023
Q4
$2.39M Sell
21,815
-15,880
-42% -$1.65M 0.04% 123
2023
Q3
$3.92M Sell
37,695
-1,210
-3% -$130K 0.08% 94
2023
Q2
$4.46M Sell
38,905
-17,791
-31% -$2.02M 0.11% 66
2023
Q1
$6.03M Sell
56,696
-7,375
-12% -$796K 0.12% 86
2022
Q4
$7.09M Buy
64,071
+24,605
+62% +$2.52M 0.16% 74
2022
Q3
$3.42M Buy
39,466
+29,692
+304% +$2.65M 0.08% 106
2022
Q2
$891K Sell
9,774
-476
-5% -$42.2K 0.02% 195
2022
Q1
$841K Sell
10,250
-7,951
-44% -$627K 0.01% 207
2021
Q4
$1.4M Sell
18,201
-25,389
-58% -$2.02M 0.03% 151
2021
Q3
$3.27M Buy
43,590
+34,583
+384% +$2.63M 0.09% 79
2021
Q2
$2.24M Sell
9,007
-3,347
-27% -$249K 0.05% 185
2021
Q1
$2.99M Sell
12,354
-40
-0.3% -$2.95K 0.06% 183
2020
Q4
$3.09M Hold
12,394
0.07% 131
2020
Q3
$981K Buy
12,394
+7,133
+136% +$559K 0.03% 124
2020
Q2
$388K Sell
5,261
-85
-2% -$6.4K 0.01% 156
2020
Q1
$392K Buy
5,346
+1,348
+34% +$106K 0.02% 114
2019
Q4
$347K Sell
3,998
-65
-2% -$5.34K 0.02% 160
2019
Q3
$326K Sell
4,063
-6,203
-60% -$497K 0.02% 154
2019
Q2
$821K Buy
10,266
+8,279
+417% +$634K 0.04% 81
2019
Q1
$158K Sell
1,987
-2,288
-54% -$171K 0.01% 149
2018
Q4
$312K Sell
4,275
-15,633
-79% -$1.1M 0.02% 139
2018
Q3
$1.35M Sell
19,908
-3,047
-13% -$194K 0.07% 87
2018
Q2
$1.33M Buy
22,955
+4,616
+25% +$260K 0.07% 77
2018
Q1
$953K Sell
18,339
-67
-0.4% -$3.62K 0.05% 105
2017
Q4
$988K Buy
18,406
+4,913
+36% +$272K 0.06% 86
2017
Q3
$824K Sell
13,493
-570
-4% -$34.6K 0.07% 72
2017
Q2
$860K Sell
14,063
-586
-4% -$35.7K 0.07% 76
2017
Q1
$878K Buy
14,649
+6,046
+70% +$367K 0.08% 64
2016
Q4
$483K Sell
8,603
-592
-6% -$34.6K 0.07% 75
2016
Q3
$548K Sell
9,195
-68
-0.7% -$3.98K 0.07% 76
2016
Q2
$509K Sell
9,263
-1,289
-12% -$68.6K 0.06% 89
2016
Q1
$533K Buy
10,552
+963
+10% +$47.2K 0.06% 79
2015
Q4
$483K Buy
+9,589
New +$483K 0.06% 71

Other funds holding MRK

Harel Insurance Investments & Financial Services's MRK Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services reduced its Merck (MRK) stake by 7.8% in Q2 2026, selling an estimated $44.5K and leaving 4,490 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Harel Insurance Investments & Financial Services first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $7.09M in Q4 2022. 2,535 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 4,490 shares of Merck worth $577K as of Q2 2026.
  • Harel Insurance Investments & Financial Services sold 380 Merck shares in Q2 2026, an estimated $44.5K.
  • Merck made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #237 holding.
  • Harel Insurance Investments & Financial Services first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • Harel Insurance Investments & Financial Services's Merck position peaked at $7.09M in Q4 2022.
  • 2,535 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.